Kumthekar, P. U., Avram, M. J., Lassman, A. B., Lin, N. U., Lee, E., Grimm, S. A., Schwartz, M., Bell Burdett, K. L., Lukas, R. V., Dixit, K., Perron, I., Zhang, H., Gradishar, W. J., Pentsova, E. I., Jeyapalan, S., Groves, M. D., Melisko, M., & Raizer, J. J. (2022). A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. Neuro-Oncology, 25(3), 557–565. https://doi.org/10.1093/neuonc/noac195

Wooster, M., McGuinness, J. E., Fenn, K. M., Singh, V. M., Franks, L. E., Lee, S., Cieremans, D., Lassman, A. B., Hershman, D. L., Crew, K. D., Accordino, M. K., Trivedi, M. S., Iwamoto, F., Welch, M. R., Haggiagi, A., Schultz, R. D., Huynh, L., Sales, E., Fisher, D., … Kalinsky, K. (2022). Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay. Clinical Breast Cancer, 22(4), e457–e462. https://doi.org/10.1016/j.clbc.2021.11.002